NCT00369239 Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis Status COMPLETED Phase PHASE4
NCT00366704 Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint Status TERMINATED Phase PHASE3
NCT00366327 Study Evaluating Bifeprunox in Patients With Schizophrenia. Status TERMINATED Phase PHASE3
NCT00364429 SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia Status TERMINATED Phase PHASE1
NCT00361543 Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia Status COMPLETED Phase PHASE4
NCT00361166 Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone Status COMPLETED Phase PHASE2
NCT00358852 Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia Status COMPLETED Phase N/A
NCT00358709 Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art Interventions Status COMPLETED Phase PHASE3
NCT00356317 Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia Status COMPLETED Phase PHASE2
NCT00352339 The New Strategy for Pharmacological Treatment in People With Schizophrenia Status UNKNOWN Phase PHASE4
NCT00351000 Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT00350935 Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study Status COMPLETED Phase N/A
NCT00350805 Measuring Time Windows in Patients With Schizophrenia and Healthy Controls Status COMPLETED Phase N/A